SCHEMBL6824201

SCHEMBL6824201

CCN(C)CC(=O)N(C)c1ccc(C)cc1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
LMNA P02545 2/20 0.42
HCRTR2 O43614 6/20 0.40
THRB P10828 1/20 0.40
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
GAA P10253 1/20 0.39
TSHR P16473 1/20 0.39
POLB P06746 1/20 0.39
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
CNR2 P34972 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL435633 0.86 ALDH1A1 (0.42) ALDH1A1RAB9ASMN1; SMN2LMNAHCRTR2
SCHEMBL19993353 0.84 POLQ (0.45) ALDH1A1LMNATHRBMEN1KMT2A
SCHEMBL8354033 0.83 KDM4E (0.41) ALDH1A1RAB9ASMN1; SMN2LMNATHRB
SCHEMBL8255637 0.83 ALDH1A1 (0.46) ALDH1A1RAB9ASMN1; SMN2LMNAHCRTR2
SCHEMBL9546363 0.81 ALDH1A1 (0.47) ALDH1A1RAB9ASMN1; SMN2LMNATHRB
SCHEMBL8354027 0.78 ALDH1A1 (0.39) ALDH1A1LMNAHCRTR2MEN1KMT2A
SCHEMBL11347316 0.77 ALDH1A1 (0.47) ALDH1A1RAB9ASMN1; SMN2LMNATHRB
SCHEMBL13887427 0.76 ALDH1A1 (0.41) ALDH1A1RAB9ASMN1; SMN2LMNAHCRTR2
SCHEMBL14174855 0.76 LMNA (0.43) ALDH1A1RAB9ASMN1; SMN2LMNATHRB
SCHEMBL4107217 0.76 ALDH1A1 (0.46) ALDH1A1RAB9ASMN1; SMN2LMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1727798-B1 NOVEL ARYL-CONTAINING 5-ACYLINDOLINONES, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2008-10-29 EP disclosed
WO-2005087726-A1 NOVEL ARYL-CONTAINING 5-ACYLINDOLINONES, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-09-22 WO disclosed
EP-0866849-B1 SOLID SUPPORT FOR USE IN CELL CULTIVATION, ESPECIALLY FOR THE CULTIVATION OF LIVER CELLS, BIOLOGICAL REACTOR CONTAINING SAID SOLID SUPPORT AND THE USE THEREOF IN A BIO-ARTIFICIAL LIVER SYSTEM ACADEMISCH ZIEKENHUISBIJ DE UN (NL) 2004-08-18 EP disclosed
WO-2003048081-A2 GLYCINAMIDES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-06-12 WO disclosed
US-6372495-B1 SOLID SUPPORT FOR THE CULTIVATION OF CELLS SEED CAPITAL INVESTMENTS-2 (SCI-2) B.V. (NL) 2002-04-16 US disclosed
EP-0866849-A1 SOLID SUPPORT FOR USE IN CELL CULTIVATION, ESPECIALLY FOR THE CULTIVATION OF LIVER CELLS, BIOLOGICAL REACTOR CONTAINING SAID SOLID SUPPORT AND THE USE THEREOF IN A BIO-ARTIFICIAL LIVER SYSTEM ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM (NL) 1998-09-30 EP disclosed
WO-1997012960-A2 SOLID SUPPORT FOR USE IN CELL CULTIVATION, ESPECIALLY FOR THE CULTIVATION OF LIVER CELLS, BIOLOGICAL REACTOR CONTAINING SAID SOLID SUPPORT AND THE USE THEREOF IN A BIO-ARTIFICIAL LIVER SYSTEM ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM (NL) 1997-04-10 WO disclosed